ProFound Therapeutics
Series A
ProFound Therapeutics: Innovating impactful disease understanding and therapeutic creation.
Founded
2022ProFound Therapeutics: Innovating impactful disease understanding and therapeutic creation.
ProFound Therapeutics, a pioneering company founded under the Flagship Pioneering umbrella, is dedicated to creating profound impacts on the understanding of biology and disease. The company's core mission is to expand the human proteome beyond traditional boundaries, revealing new possibilities for therapeutic development. ProFound Therapeutics focuses on leveraging advanced scientific insights to innovate and develop novel medicines, aiming to transform the landscape of disease treatment and patient care.
Notable figures affiliated with ProFound Therapeutics include leading scientists and industry experts from Flagship Pioneering. The company has achieved significant milestones in expanding the known human proteome, which has the potential to revolutionize drug discovery and development. By illuminating previously unknown aspects of human biology, ProFound Therapeutics is making a substantial impact on the biotechnology and pharmaceutical industries, paving the way for groundbreaking therapies and improved health outcomes.
Companies similar to ProFound Therapeutics include Vesalius Therapeutics, Ampersand Biomedicines, Alltrna and Nested Therapeutics.
ProFound Therapeutics was founded in 2022.
ProFound Therapeutics' headquarters is located in Cambridge, MA, US.
ProFound Therapeutics' most recent funding round was for $75M (USD) in May 2022.
As of May 27, 2022, ProFound Therapeutics has raised a total of $75M (USD).
ProFound Therapeutics has 35 employees as of Feb 4, 2024.
Alltrna
alltrna.com
